Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase speciesRoopali Roy, Gwendolyn Louis, Kevin R Loughlin, et al.Cell Cycle (Georgetown, Tex.)|January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validationDmitri Wiederschain, Susan Wee, Lin Chen, et al.Cancer Research|June 10, 2010
The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cellsZainab Jagani, Dmitri Wiederschain, Alice Loo, et al.Cells|November 30, 2019
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with IsatuximabThomas G Martin, Kathryn Corzo, Marielle Chiron, et al.Molecular and Cellular Biology|April 25, 2007
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesisDmitri Wiederschain, Lin Chen, Brett Johnson, et al.Plos One|September 27, 2017
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibitionMichael Lampa, Heike Arlt, Timothy He, et al.Journal for Immunotherapy of Cancer|September 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regressionIlana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.Oncoimmunology|November 23, 2020
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockadeRita Greco, Hongjing Qu, Hui Qu, et al.Frontiers in Immunology|September 14, 2020
Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma CellsChen Zhu, Zhili Song, Anlai Wang, et al.Oncotarget|May 17, 2014
Combination of PIM and JAK2 inhibitors synergistically suppresses MPN cell proliferation and overcomes drug resistanceShih-Min A Huang, Anlai Wang, Rita Greco, et al.Pageof 4